✓
Open
14 May 2025
✓
Close
16 May 2025
3
Allotment
—
✓
Listing
Wed, May 21, 2025
Price Band
₹96 to ₹101
Issue Size
29,46,000 shares (agg. up to ₹30 Cr)
Lot Size
1,200 Shares
Listing Date
Wed, May 21, 2025
Latest GMP
₹0
Est. Gain
0%
✦ AI Insight
GMP Trend
21-05-2025₹0Est. ₹101+0%
20-05-2025₹0Est. ₹101+0%
19-05-2025₹0Est. ₹101+0%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 6.47x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 39.99 | 27.05 | 20.58 | 17.74 |
| Total Income | 35.75 | 33.94 | 29.53 | 22.58 |
| Profit After Tax | 5.24 | 3.88 | 0.10 | 0.08 |
| NET Worth | 13.58 | 5.35 | 3.84 | 3.08 |
| Reserves and Surplus | 5.41 | 1.35 | ||
| Total Borrowing | 13.79 | 13.48 | 8.47 | 7.61 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Amwill Health Care Ltd. | SME | ₹59.98 Cr | ₹111 | 13.81 | ₹93.25 | -15.99% | ₹43.39 (+3.04%) |
| Sat Kartar Shopping Ltd. | SME | ₹33.80 Cr | ₹81 | 14.87 | ₹161.55 | +99.44% | ₹126.60 (-2.62%) |
| Onyx Biotec Ltd. | SME | ₹29.34 Cr | ₹61 | 26.81 | ₹56.75 | -6.97% | ₹37.60 (-4.93%) |
| Medicamen Organics Ltd. | SME | ₹10.54 Cr | ₹34 | 30.53 | ₹144.70 | +325.59% | ₹22.90 (-0.43%) |
| Quest Laboratories Ltd. | SME | ₹43.16 Cr | ₹97 | 23.03 | ₹147.35 | +51.91% | ₹94.50 (-2.53%) |
| Senores Pharmaceuticals Ltd. | Mainboard | ₹582.11 Cr | ₹391 | 39.77 | ₹557.80 | +42.66% | ₹1,405.10 (-3.68%) |
| Sai Life Sciences Ltd. | Mainboard | ₹3,042.62 Cr | ₹549 | 126.42 | ₹764.65 | +39.28% | ₹1,272.00 (-1.60%) |
| Akums Drugs & Pharmaceuticals Ltd. | Mainboard | ₹1,856.74 Cr | ₹679 | null | ₹796.25 | +17.27% | ₹664.95 (-2.60%) |
| Emcure Pharmaceuticals Ltd. | Mainboard | ₹1,952.03 Cr | ₹1008 | 34.55 | ₹1,359.15 | +34.84% | ₹1,783.20 (-1.07%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Capital expenditure towards purchase of new equipment/ machineries, etc. | 2.70 |
| 2 | Capital expenditure towards upgradation of existing manufacturing facility | 4.66 |
| 3 | Repayment/prepayme nt of certain borrowings availed by the Company | 0.99 |
| 4 | Funding working capital requirements of the Company | 14.68 |
| 5 | General Corporate Purposes | 4.43 |
| 6 | Issue Expenses | 2.30 |
| Total | 29.75 |
About Accretion Pharmaceuticals IPO
Incorporated in 2012, Accretion Pharmaceuticals Limited is a pharmaceutical company that manufactures and sells tablets, capsules, and other healthcare products. The company also offers contract manufacturing services. The Company manufactures and markets Tablets, Capsules, Oral Liquids, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), and Oral Powder (Sachet, Dry Syrup). The company also holds ISO 9001:2015, ISO 14001:2015, and ISO 22000:2005 certifications, reflecting its dedication to quality and environmental management systems. The company's manufacturing unit is located in Ahmedabad, Sanand, Gujarat. The company has expanded its global footprint, marking its presence in more than 20 countries, including regions in Africa, Southeast Asia, and the Middle East. Product Portfolio and Services Tablets and Capsules – Covering antibiotics, anti-inflammatory, pain management, cardiovascular, and gastrointestinal medicines. Oral Liquids and Syrups – Used for respiratory, pediatric, and digestive treatments. External Preparations – Including medicated lotions, gels, ointments, and dusting powders for skin care and dermatological treatm
Contact Details
Accretion Pharmaceuticals Ltd. Address29 Xcelon Ind Park 1B/h, Intas Pharmaceuticals, Vasna ChacharvadSanandAhmedabad, Gujarat, 382213+91-97148 82929compliance@accretionpharma.comVisit Website